Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP

17 Jun 2021

Abstract excerpt

Objective To determine whether CSF interleukin 8 (IL-8) concentration can help to distinguish Guillain-Barré syndrome (GBS) from chronic inflammatory demyelinating polyneuropathy (CIDP) at the initial stage of the disease. Methods We performed retrospective immunoassay of IL-8 in CSF, collected at the University Hospitals of Geneva between 2010 and 2018, from patients diagnosed with GBS (n = 45) and with CIDP (n...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Long-Term Effects of COVID-19
Share to Multiple Sclerosis Research Studies
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34140310
DOI: 10.1212/nxi.0000000000001031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDPPMID 34140310Read ↗

Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patientsSemantic proximity Read ↗

Clinical Variants and Evaluation of Clinical Severity of Guillain Barre Syndrome in a Tertiary Care Hospital of NepalSemantic proximity Read ↗

The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological FluidsSemantic proximity Read ↗

Clinical Characteristics of Guillain‐Barré syndrome in Shenzhen: A Retrospective StudySemantic proximity Read ↗

Acute/chronic inflammatory polyradiculoneuropathy.Semantic proximity Read ↗

Dysimmune Inflammatory Neuropathies (DINs): A Narrative Literature Review and European Patient PerspectivesSemantic proximity Read ↗

Nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndromeSemantic proximity Read ↗

Manifestation of Guillain-Barre Syndrome After Infection with SARS-CoV-2 versus Other Prior InfectionsSemantic proximity Read ↗

Guillain-Barr é syndrome in COVID-19: A scoping reviewSemantic proximity Read ↗

Role of altered IL-33/ST2 immune axis in the immunobiology of Guillain-Barré syndrome.Semantic proximity Read ↗

Clinical variants of Guillain-Barré syndrome in children.Semantic proximity Read ↗

Triggers of Guillain–Barré Syndrome: Campylobacter jejuni PredominatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.